Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
43.14 CAD | +0.51% | -0.44% | -1.60% |
Strengths
- Growth is a substantial asset for the company, as anticipated by dedicated analysts. Within the next three years, growth is estimated to reach 73% by 2026.
- The company's attractive earnings multiples are brought to light by a P/E ratio at 10.58 for the current year.
- This company will be of major interest to investors in search of a high dividend stock.
- There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
Weaknesses
- For the last four months, the sales outlook for the coming years has been revised downwards. No recovery of the group's activities is yet foreseen.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Life & Health Insurance
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-1.60% | 29.47B | B- | ||
+18.04% | 82.58B | B- | ||
+11.80% | 53.45B | B+ | ||
+4.12% | 49.27B | B | ||
+13.03% | 42.03B | B+ | ||
+22.95% | 40.35B | B | ||
+8.03% | 31.7B | B | ||
-15.71% | 26.12B | A- | ||
+28.68% | 24.84B | B | ||
+5.36% | 22.09B | A |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock
- Equities
- Stock Great-West Lifeco Inc. - Toronto S.E.
- Ratings Great-West Lifeco Inc.